Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
14,570,860
-
Share change
-
+14,560,860
-
Total reported value
-
$274,933,000
-
Price per share
-
$18.99
-
Number of holders
-
50
-
Value change
-
+$274,743,003
-
Number of buys
-
49
Institutional Holders of DECIPHERA PHARMACEUTICALS IN - COM (DCPH) as of Q3 2017
As of 30 Sep 2017,
DECIPHERA PHARMACEUTICALS IN - COM (DCPH) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,570,860 shares.
The largest 10 holders included
New Leaf Venture Partners, L.L.C., Viking Global Investors LP, SV Health Investors, LLC, Redmile Group, LLC, MILLENNIUM MANAGEMENT LLC, ORBIMED ADVISORS LLC, EMERALD ADVISERS INC/PA, DEERFIELD MANAGEMENT CO, EMERALD MUTUAL FUND ADVISERS TRUST, and CITADEL ADVISORS LLC.
This page lists
50
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.